Zepp Health Corporation (ZEPP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Zepp Health Corporation

NYSE: ZEPP · Real-Time Price · USD
49.48
-0.15 (-0.30%)
At close: Oct 03, 2025, 3:59 PM
49.70
0.44%
After-hours: Oct 03, 2025, 05:44 PM EDT

Zepp Health Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
427.07M 279.89M 433.03M 297.67M 295.33M 288.89M 592.07M 606.81M 668.91M 648.21M 1.03B 1.26B 1.12B 757.48M 1.65B 1.6B 1.84B 1.16B
Cost of Revenue
272.57M 175.59M 273.55M 176.79M 176.44M 182.61M 386.4M 401.14M 521.85M 544.88M 818.32M 1.02B 921.99M 605.15M 1.34B 1.28B 1.43B 900.65M
Gross Profit
154.5M 104.3M 159.48M 120.89M 118.89M 106.28M 205.67M 205.67M 147.06M 103.33M 213.61M 240.39M 200.97M 152.33M 319.27M 322.92M 403.54M 261.57M
Operating Income
-43.85M -133.45M -65M -87.89M -71.69M -115.03M 4.47M 10.93M -74.67M -151.62M -68.32M -76.34M -112.06M -155.52M 10.02M 62.32M 71.69M -50.85M
Interest Income
2.12M 4.22M 5.61M 6.6M 6.89M 7.32M 5.88M 6.79M 6.13M 4.39M 4.78M 3.41M 2.18M 2.55M 2.85M 3.56M 18.05M 5.8M
Pretax Income
-53.9M -142.58M -169.65M -92.95M -78.48M -106.49M 10.78M 3.28M -84.33M -162.41M -75.34M -52.96M -121.79M -105.67M 36.49M 55.15M 104.04M -48.79M
Net Income
-55.64M -143.37M -268.55M -92.89M -78.75M -106.78M -9.12M 3M -72.16M -137.36M -72.74M -17.81M -108.36M -88.78M 36.16M 49.22M 92.69M -40.95M
Selling & General & Admin
118.15M 147.86M 144.04M 132.65M 111.97M 124.28M 121.86M 119.52M 129.61M 136.52M 171.83M 183.99M 182.33M 161.36M 215.87M 152.22M 171.35M 158.11M
Research & Development
80.21M 89.89M 80.44M 76.12M 78.61M 97.03M 79.34M 75.23M 92.13M 118.43M 110.09M 132.74M 130.7M 146.49M 93.38M 108.39M 160.51M 154.32M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
198.35M 237.76M 224.49M 208.77M 190.58M 221.31M 201.2M 194.75M 221.73M 254.94M 281.92M 316.73M 313.03M 307.85M 309.25M 260.61M 331.86M 312.42M
Interest Expense
8.95M 9.86M 10.52M 9.04M 9.98M 10.43M 10.26M 11.77M 12.71M 13.38M 15.51M 15.73M 14.31M 11.68M 14.34M 13.46M 10.36M 6.73M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
470.93M 413.34M 498.03M 385.56M 367.02M 403.92M 587.61M 595.89M 743.58M 799.83M 1.1B 1.33B 1.24B 913M 1.64B 1.54B 1.77B 1.21B
Income Tax Expense
1.74M 798.91K 98.72M n/a 341.53K 520.56K 19.79M 478.71K -11.98M -24.85M -2.41M -35.02M -13.19M -16.76M 504.81K 6.21M 11.62M -7.7M
Shares Outstanding (Basic)
3.96M 3.86M 4.04M 4.04M 4.05M 4.06M 3.77M 4M 3.77M 3.81M 3.81M 3.81M 3.8M 3.9M 3.96M 3.95M 3.93M 3.92M
Shares Outstanding (Diluted)
3.96M 4.01M 4.04M 4.04M 4.05M 4.06M 3.77M 4M 3.81M 3.83M 3.83M 3.83M 3.84M 3.9M 4.13M 4.16M 4.12M 3.92M
EPS (Basic)
-14 -37.28 -66.96 -23.04 -19.36 -26.04 -2.4 0.06 -18.36 -35.68 -19.76 -4.48 -27.84 -22.76 9.16 12.52 23.52 -10.32
EPS (Diluted)
-14 -35.76 -66.96 -23.04 -19.36 -3.84 -0.27 0.06 -18.56 -35.84 -19.84 -4.48 -28.16 -23.04 8.96 12.16 22.40 -10.32
EBITDA
-36.2M -130.11M -134.28M -80.65M -66.05M -92.02M 7.61M 15.42M -65.43M -146.08M -59.15M -40.78M -119.08M -97.5M 36.16M 67.62M 89.53M -42.52M
EBIT
-41.31M -130.11M -138.4M -80.65M -66.05M -92.02M 3.57M 15.42M -65.43M -146.08M -59.15M -40.78M -119.08M -97.5M 36.16M 67.62M 89.53M -42.52M
Depreciation & Amortization
5.11M n/a 4.12M n/a n/a n/a 4.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a